Allogeneic transplantation for myelofibrosis with adverse risk karyotype: Attack on the clones?

This publication has 9 references indexed in Scilit:

• Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes
  Transplantation and Cellular Therapy, 2018
• MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis
  Journal of Clinical Oncology, 2018
• The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis
  Blood, 2015
• Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large National Private Claims Database
  Bone Marrow Transplantation, 2012
• DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
  Journal of Clinical Oncology, 2011
• A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
  Blood, 2010
• New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment
  Blood, 2009
• Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system [see comments]
  Blood, 1996
• THE NATURAL HISTORY OF AGNOGENIC MYELOID METAPLASIA (AMM) AND A CRITICAL EVALUATION OF ITS RELATIONSHIP WITH THE MYELOPROLIFERATIVE SYNDROME
  Medicine, 1971